JPH0521880B2 - - Google Patents
Info
- Publication number
- JPH0521880B2 JPH0521880B2 JP21341383A JP21341383A JPH0521880B2 JP H0521880 B2 JPH0521880 B2 JP H0521880B2 JP 21341383 A JP21341383 A JP 21341383A JP 21341383 A JP21341383 A JP 21341383A JP H0521880 B2 JPH0521880 B2 JP H0521880B2
- Authority
- JP
- Japan
- Prior art keywords
- monolayer
- surfactant
- molecules
- molecule
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000002798 polar solvent Substances 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 229920000642 polymer Polymers 0.000 claims abstract description 3
- 239000002356 single layer Substances 0.000 claims description 22
- 239000004094 surface-active agent Substances 0.000 claims description 18
- 239000003446 ligand Substances 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 4
- 108091034117 Oligonucleotide Proteins 0.000 claims description 3
- 108091033319 polynucleotide Proteins 0.000 claims description 2
- 102000040430 polynucleotide Human genes 0.000 claims description 2
- 239000002157 polynucleotide Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims 1
- 239000010410 layer Substances 0.000 abstract description 12
- 239000013554 lipid monolayer Substances 0.000 abstract description 10
- 229920002521 macromolecule Polymers 0.000 abstract 5
- 150000002632 lipids Chemical class 0.000 description 21
- 102000005962 receptors Human genes 0.000 description 9
- 108020003175 receptors Proteins 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 229920001308 poly(aminoacid) Polymers 0.000 description 5
- 239000013078 crystal Substances 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- 238000002424 x-ray crystallography Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000008857 Ferritin Human genes 0.000 description 2
- 108050000784 Ferritin Proteins 0.000 description 2
- 238000008416 Ferritin Methods 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex⢠Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- -1 alkynyl carboxylic acids Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000635 electron micrograph Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 230000005661 hydrophobic surface Effects 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 125000003473 lipid group Chemical group 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000002902 organometallic compounds Chemical class 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
- 125000002228 disulfide group Chemical group 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine group Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 150000001282 organosilanes Chemical class 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
- C30B7/14—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions the crystallising materials being formed by chemical reactions in the solution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D1/00—Processes for applying liquids or other fluent materials
- B05D1/18—Processes for applying liquids or other fluent materials performed by dipping
- B05D1/185—Processes for applying liquids or other fluent materials performed by dipping applying monomolecular layers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/54—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D1/00—Processes for applying liquids or other fluent materials
- B05D1/18—Processes for applying liquids or other fluent materials performed by dipping
- B05D1/20—Processes for applying liquids or other fluent materials performed by dipping substances to be applied floating on a fluid
- B05D1/202—Langmuir Blodgett films (LB films)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/30—Self-sustaining carbon mass or layer with impregnant or other layer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31536—Including interfacial reaction product of adjacent layers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/31504—Composite [nonstructural laminate]
- Y10T428/31725—Of polyamide
- Y10T428/31768—Natural source-type polyamide [e.g., casein, gelatin, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nanotechnology (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Composite Materials (AREA)
- Manufacturing & Machinery (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
ãçºæã®è©³çްãªèª¬æã
æ¬çºæã®èæ¯
æ¬çºæã®åé
å€ãã®ææ©ååã¯çµæ¶ååã¯é
åããããšãã§
ããããå€å€§ãªåŽåãèŠããéšåçãªæåããã
ãããããªãããšãå€ããåºç¯ãªååãé ååã¯
çµæ¶åããããšãã§ããã°ãååæ§é ã®æ°ããªç¥
èŠã容æã«åŸãããšãã§ããã®ã¿ãªãããããã®
ååã®æ°ããªçšéãéæããããšãã§ããã§ãã
ãã
ããããå€å€§ãªåŽåãèŠããéšåçãªæåããã
ãããããªãããšãå€ããåºç¯ãªååãé ååã¯
çµæ¶åããããšãã§ããã°ãååæ§é ã®æ°ããªç¥
èŠã容æã«åŸãããšãã§ããã®ã¿ãªãããããã®
ååã®æ°ããªçšéãéæããããšãã§ããã§ãã
ãã
äžã€ã®èå³ããé åã¯ååã®æ§é åã³æ§é äžã®
é¢ä¿ãç ç©¶ããããšã§ãããäŸãã°ãæäœåã³é µ
çŽ ã¯èå³ããå容äœååïŒreceptor moleculeïŒ
ã§ããããã®æ§é åã³ãã®é äœåãšã®é¢ä¿ã¯éåžž
ã«ç§åŠçã«èå³ãããããã®è§£æã«ããå®çšçãª
çšéãå°ãåºãããšãã§ããããããããããã
ã®åååã³ããããã®é äœåãšã®é¯äœã¯ãâç·
çµæ¶åŠçšã®è©Šæãšããã®ãéåžžã«é£ãããã€ãã
é¢ä¿ãç ç©¶ããããšã§ãããäŸãã°ãæäœåã³é µ
çŽ ã¯èå³ããå容äœååïŒreceptor moleculeïŒ
ã§ããããã®æ§é åã³ãã®é äœåãšã®é¢ä¿ã¯éåžž
ã«ç§åŠçã«èå³ãããããã®è§£æã«ããå®çšçãª
çšéãå°ãåºãããšãã§ããããããããããã
ã®åååã³ããããã®é äœåãšã®é¯äœã¯ãâç·
çµæ¶åŠçšã®è©Šæãšããã®ãéåžžã«é£ãããã€ãã
çµæ¶åã¯ãŸãååŠç©è³ªã«éçµæ¶ç¶æ
ã§ã¯åŸãã
ãªããããªæ§è³ªãä»äžãããçµæ¶ååã¯é åãã
ååã¯ãå åŠãé»åå·¥åŠã®åéã«ãããŠããŸãæ§
é çŽ åçãšããŠäœ¿çšããããšãã§ããã
ãªããããªæ§è³ªãä»äžãããçµæ¶ååã¯é åãã
ååã¯ãå åŠãé»åå·¥åŠã®åéã«ãããŠããŸãæ§
é çŽ åçãšããŠäœ¿çšããããšãã§ããã
å
è¡æè¡ã®èª¬æ
ããšãªãã³ã®éç¹ç°æ§åžçåã³ïŒè§åœ¢ã®é
åã¯
ããã ããŒã°ïŒFrombergïŒã«ããå ±åããã
ïŒããã€ãã€ãŒãïŒNatureïŒ231ïŒ1971ïŒã267â
268ïŒãïŒè§åœ¢ã®ããšãªãã³çã¯ãŸããªãããåå±€
ã®äžååšäžã§ççŽ æºäžã«åœ¢æãããããã€ãŒããŒ
ïŒFederïŒåã³ã®ã¢ãšããŒïŒGiaeverïŒããžã€ãŒã
ã«ã»ãªãã»ã³ãã€ãã»ã¢ã³ãã»ã€ã³ã¿ãŒããšã€
ã¹ã»ãµã€ãšã³ã¹ïŒJ.of.Colloid and Interface
ScienceïŒ78ã144â154ïŒ1980ïŒãåç §ãïŒ
ENã1982幎10æïŒæ¥å·ã19é ã«ã¯ãã¢ã«ããã«
ã«ã«ãã³é žã®é åéåã«åå±€ã䜿çšããããšãèš
èŒãããŠããã
ããã ããŒã°ïŒFrombergïŒã«ããå ±åããã
ïŒããã€ãã€ãŒãïŒNatureïŒ231ïŒ1971ïŒã267â
268ïŒãïŒè§åœ¢ã®ããšãªãã³çã¯ãŸããªãããåå±€
ã®äžååšäžã§ççŽ æºäžã«åœ¢æãããããã€ãŒããŒ
ïŒFederïŒåã³ã®ã¢ãšããŒïŒGiaeverïŒããžã€ãŒã
ã«ã»ãªãã»ã³ãã€ãã»ã¢ã³ãã»ã€ã³ã¿ãŒããšã€
ã¹ã»ãµã€ãšã³ã¹ïŒJ.of.Colloid and Interface
ScienceïŒ78ã144â154ïŒ1980ïŒãåç §ãïŒ
ENã1982幎10æïŒæ¥å·ã19é ã«ã¯ãã¢ã«ããã«
ã«ã«ãã³é žã®é åéåã«åå±€ã䜿çšããããšãèš
èŒãããŠããã
æ¬çºæã®èŠçŽ
åå±€ã圢æããç颿޻æ§å€ã®æ¥µæ§ç«¯éšã«ãåå
ãå ±æçµåçåã¯éå ±æçµåçã«çµåãããšãèª
ç±ãšãã«ã®ãŒã®äœãç¶æ ã«é åããããšãã§ãã
ååã®æŽç¶ãšããé åãåŸããããç¹ã«ãææ©é«
ååã䜿çšããããšãã§ãããåŸãããèŠåæ£ã
ãé åããå±€ã¯ããã«èŠåæ£ããé åã®å±€ãèšã
ãããã®ååãšããŠäœ¿çšãããã倿§ããããæ¶
æ©ãããããããã¯ãªãããåå±€ããåé¢ããã
ããããšãã§ãããŸãâç·çµæ¶åŠã®è©ŠæãšããŠ
䜿çšããããæŽ»æ§æåãšããŠçš®ã ã®çšéã«äœ¿çšã
ããããããšãã§ããã
ãå ±æçµåçåã¯éå ±æçµåçã«çµåãããšãèª
ç±ãšãã«ã®ãŒã®äœãç¶æ ã«é åããããšãã§ãã
ååã®æŽç¶ãšããé åãåŸããããç¹ã«ãææ©é«
ååã䜿çšããããšãã§ãããåŸãããèŠåæ£ã
ãé åããå±€ã¯ããã«èŠåæ£ããé åã®å±€ãèšã
ãããã®ååãšããŠäœ¿çšãããã倿§ããããæ¶
æ©ãããããããã¯ãªãããåå±€ããåé¢ããã
ããããšãã§ãããŸãâç·çµæ¶åŠã®è©ŠæãšããŠ
䜿çšããããæŽ»æ§æåãšããŠçš®ã ã®çšéã«äœ¿çšã
ããããããšãã§ããã
å
·äœç宿œæ
æ§ã®èª¬æ
ãªãããã®åå±€ã圢æããååãçšããŠææã®
ååãé åãããããšã«ãããæ°èŠãªå±€åã¯ç©å±€
ãåŸãããšãã§ããããªãããååã¯ææã®åå
ãšå¯éçã«çµåããææã®ååã®èŠåæ£ããé å
ããæçµçã«åé¢ããããšãã§ãããåœè©²ææå
åã¯ããªãããååãšå ±æçµåçåã¯éå ±æçµå
çã«çµåããããšãã§ããæ¥µæ§æº¶åªã«å¯ŸããŠå¿ èŠ
ãªå¯æº¶æ§ãæããèŠåæ£ããäºæ¬¡å ã®é åã圢æ
ããããšãã§ãããã®ã«éãããã
ååãé åãããããšã«ãããæ°èŠãªå±€åã¯ç©å±€
ãåŸãããšãã§ããããªãããååã¯ææã®åå
ãšå¯éçã«çµåããææã®ååã®èŠåæ£ããé å
ããæçµçã«åé¢ããããšãã§ãããåœè©²ææå
åã¯ããªãããååãšå ±æçµåçåã¯éå ±æçµå
çã«çµåããããšãã§ããæ¥µæ§æº¶åªã«å¯ŸããŠå¿ èŠ
ãªå¯æº¶æ§ãæããèŠåæ£ããäºæ¬¡å ã®é åã圢æ
ããããšãã§ãããã®ã«éãããã
æ¬çºæã®æ¹æ³ã¯ããªãããã®åå±€ã圢æããå
èšåå±€ãæ¥µæ§æº¶åªäžã®é©åœãªæ¿åºŠã®ææã®ååãš
æ¥è§Šããåœè©²ææååã以äžããªãšã³ãã
ïŒlyendïŒãšããããäœãèªç±ãšãã«ã®ãŒç¶æ ãå
ãã®ã«ååãªæéãããããªãšã³ãã®èŠåæ£ãã
é åãäŸãã°çµæ¶ãåŸãå·¥çšãå«ããèŠåæ£ãã
é åã®ç®çåã³ãªãšã³ãã®æ§è³ªã«å¿ããŠãªãšã³ã
ãšçžäºäœçšããä»å çãªååãå ããŠä»å çãªå±€
ã圢æãããã€ãŠäœãèªç±ãšãã«ã®ãŒå±€é åã®ç©
å±€ãåŸãããšãã§ããã
èšåå±€ãæ¥µæ§æº¶åªäžã®é©åœãªæ¿åºŠã®ææã®ååãš
æ¥è§Šããåœè©²ææååã以äžããªãšã³ãã
ïŒlyendïŒãšããããäœãèªç±ãšãã«ã®ãŒç¶æ ãå
ãã®ã«ååãªæéãããããªãšã³ãã®èŠåæ£ãã
é åãäŸãã°çµæ¶ãåŸãå·¥çšãå«ããèŠåæ£ãã
é åã®ç®çåã³ãªãšã³ãã®æ§è³ªã«å¿ããŠãªãšã³ã
ãšçžäºäœçšããä»å çãªååãå ããŠä»å çãªå±€
ã圢æãããã€ãŠäœãèªç±ãšãã«ã®ãŒå±€é åã®ç©
å±€ãåŸãããšãã§ããã
æ¬çºæã«äœ¿çšããç©è³ªã¯ããªãããç颿޻æ§å€
ã®åå±€ã圢æããç©è³ªããªãšã³ãïŒäºçŽåã¯äžçŽ
以äžã§ãããïŒãšãæ¥µæ§æº¶åªãšãæ¥µæ§æº¶åªã«å¯Ÿã
ãæ·»å å€ãšãç¹å¥ã®çšéã«ç¹å®ã®ç©è³ªã§ããã
ã®åå±€ã圢æããç©è³ªããªãšã³ãïŒäºçŽåã¯äžçŽ
以äžã§ãããïŒãšãæ¥µæ§æº¶åªãšãæ¥µæ§æº¶åªã«å¯Ÿã
ãæ·»å å€ãšãç¹å¥ã®çšéã«ç¹å®ã®ç©è³ªã§ããã
ãªãããåå±€ã圢æããç©è³ªã¯ããªãããé£é
ïŒèŠªæ²¹æ§é åïŒã極æ§åºïŒèŠªæ°Žæ§é åïŒåã³ãªãšã³
ãã«å¯ŸããŠå ±æçµåãéå ±æçµåã®ããããã®æ
æ§ã§æ®éå¯éçã«çµåããéšåãæããããªãã
ãéšåã¯äžè¬ã«çŽïŒã24ãéåžžã¯çŽïŒã18ã®ççŽ
ååãæããçåæ°ŽçŽ é£éã§ããã飜åããŠããŠ
ãäžé£œåã§ããããïŒåååœãïŒãïŒåã®é£éã
æãåŸãããªãããåºã¯ã倩ç¶ã®çްèèçã®æ§æ
èŠçŽ ãšããŠããªããœãŒã ã®ããã«ãåå±€ã圢æã
ããã®ãšããŠãå è¡æè¡ã®åºç¯ã«èšèŒãããŠã
ããæ¥µæ§åºã¯éã€ãªã³æ§ã§ãã€ãªã³æ§ïŒã¢ããªã³
æ§åã¯ã«ããªã³æ§ïŒã§ããããããªã¹ããšãŒã
åºãçé žãšã¹ãã«åºãã«ã«ãã³é žåºãã¢ããåºã
第åçŽã¢ã³ã¢ãã¢åºãç¡«é žåºãã¹ã«ãããŒãåºã
æ°Žé žåºãã¡ã«ã«ããåºçã®çš®ã ã®åºããããäžã€
以äžã®ãªãããåºãåäžååäžã«ååšããŠããã
ããã«ããããã®åºãäžã€ä»¥äžåæã«äœ¿çšããã
ãšãã§ããã
ïŒèŠªæ²¹æ§é åïŒã極æ§åºïŒèŠªæ°Žæ§é åïŒåã³ãªãšã³
ãã«å¯ŸããŠå ±æçµåãéå ±æçµåã®ããããã®æ
æ§ã§æ®éå¯éçã«çµåããéšåãæããããªãã
ãéšåã¯äžè¬ã«çŽïŒã24ãéåžžã¯çŽïŒã18ã®ççŽ
ååãæããçåæ°ŽçŽ é£éã§ããã飜åããŠããŠ
ãäžé£œåã§ããããïŒåååœãïŒãïŒåã®é£éã
æãåŸãããªãããåºã¯ã倩ç¶ã®çްèèçã®æ§æ
èŠçŽ ãšããŠããªããœãŒã ã®ããã«ãåå±€ã圢æã
ããã®ãšããŠãå è¡æè¡ã®åºç¯ã«èšèŒãããŠã
ããæ¥µæ§åºã¯éã€ãªã³æ§ã§ãã€ãªã³æ§ïŒã¢ããªã³
æ§åã¯ã«ããªã³æ§ïŒã§ããããããªã¹ããšãŒã
åºãçé žãšã¹ãã«åºãã«ã«ãã³é žåºãã¢ããåºã
第åçŽã¢ã³ã¢ãã¢åºãç¡«é žåºãã¹ã«ãããŒãåºã
æ°Žé žåºãã¡ã«ã«ããåºçã®çš®ã ã®åºããããäžã€
以äžã®ãªãããåºãåäžååäžã«ååšããŠããã
ããã«ããããã®åºãäžã€ä»¥äžåæã«äœ¿çšããã
ãšãã§ããã
ãªããããäŸç€ºããã°ããªã¹ããªãªããããäŸ
ãã°ãããªã¹ãã¢ããžã«ç颿޻æ§å€ãäŸãã°ãã
ãªã¹ãã¢ããžã«ã³ãªã³ãããªã¹ãã¢ããžã«ã€ãã·
ããŒã«åã³ããªã¹ãã¢ããžã«ãšã¿ããŒã«ã¢ãã³ïŒ
ã«ã«ãžãªãªãã³ãã¬ã·ãã³ãã¹ãã€ã³ãŽããšãª
ã³ãã»ã¬ããã·ãŒããã¬ã³ã°ãªãªã·ãçãããã
ååããªãããã«å ±åœ¹çµåãããããšåã³é äœå
ãå容äœã«ã€ããŠã¯ç±³åœç¹èš±ç¬¬4193983å·ãåç §ã
ãã°ãããªã¹ãã¢ããžã«ç颿޻æ§å€ãäŸãã°ãã
ãªã¹ãã¢ããžã«ã³ãªã³ãããªã¹ãã¢ããžã«ã€ãã·
ããŒã«åã³ããªã¹ãã¢ããžã«ãšã¿ããŒã«ã¢ãã³ïŒ
ã«ã«ãžãªãªãã³ãã¬ã·ãã³ãã¹ãã€ã³ãŽããšãª
ã³ãã»ã¬ããã·ãŒããã¬ã³ã°ãªãªã·ãçãããã
ååããªãããã«å ±åœ¹çµåãããããšåã³é äœå
ãå容äœã«ã€ããŠã¯ç±³åœç¹èš±ç¬¬4193983å·ãåç §ã
ç颿޻æ§å€ããªãšã³ãã«çµåãããåºã¯ç颿޻
æ§å€ã®æ¥µæ§æ«ç«¯éšã«ååšãããªãšã³ãã®æ§è³ªã«äŸ
åãããå ±æå¯éçµåãæãŸããå Žåããžã¹ã«ã
ã€ãåºãç¹ã«æçšã§ããããã®å Žåãªãããçé¢
掻æ§å€ãšãªãšã³ãã¯ããããé žåã«ããçµåãã
ãããªåºãæãããååŠçã«åæããããã®ä»ã®
åºã«ã¯ãããã©ãŸãã€ããããšã¹ãã«çã®ãããª
ååããããããã©ãŸåºã¯ããã²ã³ã§ã¢ã«ãã«å
ããæ¬¡ãã§éå ã«ããåæããããšãã§ãããã€
ããåºã¯ãªããœåºãšã¢ããåºåœã¯ããã©ãžã³åºãš
ã®éã«åœ¢æããæ¬¡ãã§ç©ãããªé žã§åŠçããããš
ã«ããåæããããšãã§ããããšã¹ãã«ã¯ã«ã«ã
ãžã€ããã§æŽ»æ§åããã«ã«ããã·ã«åºãã容æã«
圢æããããšãã§ããããšã¹ãã«ã¯æ¬¡ãã§ç©ãã
ãªé žåã¯å¡©åºãçšããŠå®¹æã«å æ°Žåè§£ããããšã
ã§ããããããã®èª¬æã¯éå®çãªãã®ã§ã¯ãªãã
åŸã«åæããŠïŒã€ã®ååãéåžžã¯æåã®ïŒã€ã®å
åã«ãã©ãããšãã§ããåºã圢æããäžè¬çãªæ¹
æ³ã幟ã€ãäŸç€ºãããã®ã«ãããªãã
æ§å€ã®æ¥µæ§æ«ç«¯éšã«ååšãããªãšã³ãã®æ§è³ªã«äŸ
åãããå ±æå¯éçµåãæãŸããå Žåããžã¹ã«ã
ã€ãåºãç¹ã«æçšã§ããããã®å Žåãªãããçé¢
掻æ§å€ãšãªãšã³ãã¯ããããé žåã«ããçµåãã
ãããªåºãæãããååŠçã«åæããããã®ä»ã®
åºã«ã¯ãããã©ãŸãã€ããããšã¹ãã«çã®ãããª
ååããããããã©ãŸåºã¯ããã²ã³ã§ã¢ã«ãã«å
ããæ¬¡ãã§éå ã«ããåæããããšãã§ãããã€
ããåºã¯ãªããœåºãšã¢ããåºåœã¯ããã©ãžã³åºãš
ã®éã«åœ¢æããæ¬¡ãã§ç©ãããªé žã§åŠçããããš
ã«ããåæããããšãã§ããããšã¹ãã«ã¯ã«ã«ã
ãžã€ããã§æŽ»æ§åããã«ã«ããã·ã«åºãã容æã«
圢æããããšãã§ããããšã¹ãã«ã¯æ¬¡ãã§ç©ãã
ãªé žåã¯å¡©åºãçšããŠå®¹æã«å æ°Žåè§£ããããšã
ã§ããããããã®èª¬æã¯éå®çãªãã®ã§ã¯ãªãã
åŸã«åæããŠïŒã€ã®ååãéåžžã¯æåã®ïŒã€ã®å
åã«ãã©ãããšãã§ããåºã圢æããäžè¬çãªæ¹
æ³ã幟ã€ãäŸç€ºãããã®ã«ãããªãã
éå
±æçµåãæãŸããå Žåãé
äœåâå容äœã®
éå ±æçµåãçšããããšãã§ããããããã³ãã
ãªãã³ãåºè³ªåã³è£é µçŽ ã®ãããªåºç¯å²ãªé äœå
ãçšããããšãã§ãããã¬ã¯ãã³ã¯ç ç³çãšãšã
ã«äœ¿çšããããšãã§ããããŸããéåžžçŽïŒã30ã®
å¡©åºã®ç颿޻æ§å€ãšçµåããå°ããªçžè£æ§ãªãªãŽ
ãã¯ã¬ãªãããæããRNAåã¯DNAã®ãããã
ã䜿çšããããšã«ãããçžè£æ§ãã¯ã¬ãªããé£é
ãçšããããšãã§ããã
éå ±æçµåãçšããããšãã§ããããããã³ãã
ãªãã³ãåºè³ªåã³è£é µçŽ ã®ãããªåºç¯å²ãªé äœå
ãçšããããšãã§ãããã¬ã¯ãã³ã¯ç ç³çãšãšã
ã«äœ¿çšããããšãã§ããããŸããéåžžçŽïŒã30ã®
å¡©åºã®ç颿޻æ§å€ãšçµåããå°ããªçžè£æ§ãªãªãŽ
ãã¯ã¬ãªãããæããRNAåã¯DNAã®ãããã
ã䜿çšããããšã«ãããçžè£æ§ãã¯ã¬ãªããé£é
ãçšããããšãã§ããã
ãªãšã³ãã®æ§è³ªããªãããã®æ§è³ªããªãšã³ãã®
ææã®å 填床çã«å¿ããŠãåå±€ã圢æããããã«
åäžã®ãªãããåã¯æ··åç©ã䜿çšãããå žåçã«
ã¯ãªãšã³ããšçµåãåŸãïŒã50ã¢ã«ïŒ ã®ãªããã
ç颿޻æ§å€ãçšããã
ææã®å 填床çã«å¿ããŠãåå±€ã圢æããããã«
åäžã®ãªãããåã¯æ··åç©ã䜿çšãããå žåçã«
ã¯ãªãšã³ããšçµåãåŸãïŒã50ã¢ã«ïŒ ã®ãªããã
ç颿޻æ§å€ãçšããã
ãªãšã³ãã¯å¹Ÿã€ãã®ç¹ã§å¶éãããã ãã§ã
ããéåžžããªãšã³ãã¯å°ããšãçŽ1000ãæ®éã¯å°
ããšãçŽ2000ã奜ãŸããã¯5000以äžã®ååéãæ
ããã§ããããã»ãšãã©ã®å Žåãªãšã³ãã¯ææ©å
åã§ããããé屿æ©ååç©ããªã«ã¬ãã·ã©ã³ç
ã§ãããããªãšã³ãã¯ãŸãããªãããç颿޻æ§å€
ã®åå±€ã圢æãããããã«æ¥µæ§æº¶åªã«å¯Ÿããåå
ãªæº¶è§£åºŠãæããªããã°ãªããªããã»ãšãã©ã®å Ž
åã䜿çšããæ¥µæ§æº¶åªã¯æ°Žæ§åªäœã§ããããå€ã
ã®çš®é¡ã®ææ©æº¶åªãããã«å«ãŸããããšãã§ã
ããéåžžãææ©æº¶åªã¯60äœç©ïŒ ãè¶ ããã奜ãŸã
ãã¯çŽ40äœç©ïŒ ãè¶ ããªããã¡ã¿ããŒã«ããšã¿ã
ãŒã«ã®ãããªã¢ã«ã³ãŒã«é¡ãïŒïŒ®âãžã¡ãã«ã
ã«ã ã¢ããã®ãããªã¢ããé¡ãã¢ã»ãã³ã®ãããª
ã±ãã³é¡çã®çš®ã ã®æ°Žãšçžæº¶æ§ã®æº¶åªã䜿çšãã
ããšãã§ãããç¹å®ã®å Žåã«ã¯æ°Žãšã®çžæº¶æ§ã¯å¿
èŠã§ã¯ãªããå ãã«æ°Žã«æº¶è§£ããã ãã®ææ©æº¶åª
ã䜿çšããããšãã§ããã
ããéåžžããªãšã³ãã¯å°ããšãçŽ1000ãæ®éã¯å°
ããšãçŽ2000ã奜ãŸããã¯5000以äžã®ååéãæ
ããã§ããããã»ãšãã©ã®å Žåãªãšã³ãã¯ææ©å
åã§ããããé屿æ©ååç©ããªã«ã¬ãã·ã©ã³ç
ã§ãããããªãšã³ãã¯ãŸãããªãããç颿޻æ§å€
ã®åå±€ã圢æãããããã«æ¥µæ§æº¶åªã«å¯Ÿããåå
ãªæº¶è§£åºŠãæããªããã°ãªããªããã»ãšãã©ã®å Ž
åã䜿çšããæ¥µæ§æº¶åªã¯æ°Žæ§åªäœã§ããããå€ã
ã®çš®é¡ã®ææ©æº¶åªãããã«å«ãŸããããšãã§ã
ããéåžžãææ©æº¶åªã¯60äœç©ïŒ ãè¶ ããã奜ãŸã
ãã¯çŽ40äœç©ïŒ ãè¶ ããªããã¡ã¿ããŒã«ããšã¿ã
ãŒã«ã®ãããªã¢ã«ã³ãŒã«é¡ãïŒïŒ®âãžã¡ãã«ã
ã«ã ã¢ããã®ãããªã¢ããé¡ãã¢ã»ãã³ã®ãããª
ã±ãã³é¡çã®çš®ã ã®æ°Žãšçžæº¶æ§ã®æº¶åªã䜿çšãã
ããšãã§ãããç¹å®ã®å Žåã«ã¯æ°Žãšã®çžæº¶æ§ã¯å¿
èŠã§ã¯ãªããå ãã«æ°Žã«æº¶è§£ããã ãã®ææ©æº¶åª
ã䜿çšããããšãã§ããã
ç¹ã«èå³ãããã®ä»ã®çš®é¡ã®ãªãšã³ãååç©ã¯
ããªã¢ããé žã§ãããããªã¢ããé žã®äŸã¯ããªã
ãããåã³èçœè³ªã§ãããæäœïŒäŸãã°IgGã
IgMãIgAãIgGãIgEïŒãé µçŽ åã³å€©ç¶ã®å容äœ
ïŒäŸãã°ã¢ããžã³ã现è衚é¢å容åã³ãã¹ãã³ïŒ
ã®ãããªåºç¯ãªããªã¢ããé žã¯åå®¹äœæŽ»æ§ãæã
ããããªã¢ããé žãåå®¹äœæŽ»æ§ãæããªãå Žåã
å®èœåãäŸãã°å¯èœãªã¡ã«ã«ããåºãå°å ¥ãã
ããååäžã®å©çšå¯èœãªã¡ã«ã«ããåºã䜿çšãã
ããšãå¿ èŠã§ããããŸããããªã¢ããé žã倩ç¶ã®
å容äœãäŸãã°ã€ããžã³ãæäœçã«çµåããããš
ãã§ããã
ããªã¢ããé žã§ãããããªã¢ããé žã®äŸã¯ããªã
ãããåã³èçœè³ªã§ãããæäœïŒäŸãã°IgGã
IgMãIgAãIgGãIgEïŒãé µçŽ åã³å€©ç¶ã®å容äœ
ïŒäŸãã°ã¢ããžã³ã现è衚é¢å容åã³ãã¹ãã³ïŒ
ã®ãããªåºç¯ãªããªã¢ããé žã¯åå®¹äœæŽ»æ§ãæã
ããããªã¢ããé žãåå®¹äœæŽ»æ§ãæããªãå Žåã
å®èœåãäŸãã°å¯èœãªã¡ã«ã«ããåºãå°å ¥ãã
ããååäžã®å©çšå¯èœãªã¡ã«ã«ããåºã䜿çšãã
ããšãå¿ èŠã§ããããŸããããªã¢ããé žã倩ç¶ã®
å容äœãäŸãã°ã€ããžã³ãæäœçã«çµåããããš
ãã§ããã
ãã®ä»ã®èå³ããååç©ã¯ããªãã¯ã¬ãªããã
åã¯DNAåã¯RNAã®ãããªæ žé žã§ãããDNA
ãšããŠã¯æè²äœã®ãã®ãæè²äœå€ã®ãã®ãè²çŽ
äœãäŸãã°èç·äœã®ãã®åã¯ããã³ã³ããªã¢ã®ã
ã®ããŽã€ãŒã«ã¹ã®ãã®çããããRNAãšããŠã¯
ã¡ãã»ã³ãžã€ãŒRNAããã©ã³ã¹ãã¢ãŒRNAããª
ããœãŒã RNAãåæRNAçãããããªãªãŽãã¯
ã¬ãªããããªãããã«çµåããé äœåãšããŠäœ¿çš
ããããšã«ãããçžè£çé åé åº
ïŒcomplementary sequenceïŒãæããæ žé žé å
é åºãšçµåããããšãã§ããããããã¯æ¬¡ãã§äº
次å çã«é åããåäžçµæã®ãã¯ã¬ãªããé åé
åºã®èŠåæ£ããé åã圢æããã
åã¯DNAåã¯RNAã®ãããªæ žé žã§ãããDNA
ãšããŠã¯æè²äœã®ãã®ãæè²äœå€ã®ãã®ãè²çŽ
äœãäŸãã°èç·äœã®ãã®åã¯ããã³ã³ããªã¢ã®ã
ã®ããŽã€ãŒã«ã¹ã®ãã®çããããRNAãšããŠã¯
ã¡ãã»ã³ãžã€ãŒRNAããã©ã³ã¹ãã¢ãŒRNAããª
ããœãŒã RNAãåæRNAçãããããªãªãŽãã¯
ã¬ãªããããªãããã«çµåããé äœåãšããŠäœ¿çš
ããããšã«ãããçžè£çé åé åº
ïŒcomplementary sequenceïŒãæããæ žé žé å
é åºãšçµåããããšãã§ããããããã¯æ¬¡ãã§äº
次å çã«é åããåäžçµæã®ãã¯ã¬ãªããé åé
åºã®èŠåæ£ããé åã圢æããã
ãã®ä»ã®çš®é¡ã®ååç©ããªãšã³ããšããŠçšãã
ããšãã§ããããã®ãããªååç©ã®äŸã¯ããã ã
èç·çŽ ãçš®ã ã®ãªãã·ããŒãŒçã®ãããªé屿æ©
ååç©ã§ããã
ããšãã§ããããã®ãããªååç©ã®äŸã¯ããã ã
èç·çŽ ãçš®ã ã®ãªãã·ããŒãŒçã®ãããªé屿æ©
ååç©ã§ããã
ãªãšã³ãçžã¯ç¬¬ïŒå±€åã¯å€éåååå±€ã圢æã
ãããã®åºç€ãšããããšãã§ãããäŸãã°ãæäœ
ãçšããå Žåãæäœã«çµåããClqãRfãããª
ãŒã¬ãŠã¹èçœè³ªïŒ¡ãã®ä»ã®ç¹å®ã®å容äœãå ãã
ããšãã§ããããŸããæäœãçµåãããããã³ãš
ç°ããããã³ããæäœã«æ¥åããïŒconjugateïŒ
ããšã«ãããæäœã«ããã«çµåæ§ãä»äžãããã
ã«å€æ§ããããšãã§ãããã¬ã¯ãã³ã¯ä»å çå±€ã
äžããããã«ç ç³ãšãšãã«äœ¿çšããããšãã§ã
ãããªãšã³ããä»å çãªå容äœã®é äœåãšããŠçš
ããŠãå容äœã®å±€ãèšããããšãã§ãããæ¬çºæ
ãçšããããšãã§ããçš®ã ã®çšéã«çš®ã ã®ååç©
ãçšããããšãã§ããã
ãããã®åºç€ãšããããšãã§ãããäŸãã°ãæäœ
ãçšããå Žåãæäœã«çµåããClqãRfãããª
ãŒã¬ãŠã¹èçœè³ªïŒ¡ãã®ä»ã®ç¹å®ã®å容äœãå ãã
ããšãã§ããããŸããæäœãçµåãããããã³ãš
ç°ããããã³ããæäœã«æ¥åããïŒconjugateïŒ
ããšã«ãããæäœã«ããã«çµåæ§ãä»äžãããã
ã«å€æ§ããããšãã§ãããã¬ã¯ãã³ã¯ä»å çå±€ã
äžããããã«ç ç³ãšãšãã«äœ¿çšããããšãã§ã
ãããªãšã³ããä»å çãªå容äœã®é äœåãšããŠçš
ããŠãå容äœã®å±€ãèšããããšãã§ãããæ¬çºæ
ãçšããããšãã§ããçš®ã ã®çšéã«çš®ã ã®ååç©
ãçšããããšãã§ããã
æ¬çºæã®å®æœã«ãããŠã¯ããŸãåå±€ã圢æã
ããåå±€ã¯ç©ºæ°âæ°Žã®çé¢åã¯ææ©æº¶åªâæ°Žã®ç
é¢ã«åœ¢æããããšãã§ãããŸãçé¢ããé€å»ããŠ
çæ°Žæ§è¡šé¢ãäŸãã°ççŽ ã«çµåããããšãã§ã
ããåå±€ã圢æãããšããããæ°Žæ§åªäœäžã§ãªãš
ã³ããšæ¥è§Šããããéåžžãç©ãããªæž©åºŠãçšãã
ããããäžè¬ã«ïŒã50âã®ç¯å²ã§ããããªãšã³ã
ã®æ§è³ªã«ãããæº¶æ¶²ãç·©è¡ããããå®å®å€ãå ã
ãããåã¯ã€ãªã³ã®åŒ·ããç²åºŠçãä»äžãããã
ã«ãã®ä»ã®æ·»å å€ãå ããããšãã§ãããå Žåã«
ãã€ãŠã¯æ·»å å€ãå€ããããšã«ããããªãšã³ãã®
ã³ã³ããªã¡ãŒã·ãšã³ãå€ããŠç°ãæçµçæç©ãåŸ
ãããšãã§ããããªãããç颿޻æ§å€ãšãªãšã³ã
ã®çµåãããé ååãèµ·ãã®ã«ååãªæéæå®æž©
床ã«ä¿æïŒã€ã³ããŠããŒãïŒãããå Žåã«ãã€ãŠ
ã¯ãç³»ã®çµæ¶åãä¿é²ããããã«ã枩床ããµã€ã¯
ã«åãããæº¶æ¶²æ¡ä»¶ãå€ãããããã®ãæãŸã
ãã
ããåå±€ã¯ç©ºæ°âæ°Žã®çé¢åã¯ææ©æº¶åªâæ°Žã®ç
é¢ã«åœ¢æããããšãã§ãããŸãçé¢ããé€å»ããŠ
çæ°Žæ§è¡šé¢ãäŸãã°ççŽ ã«çµåããããšãã§ã
ããåå±€ã圢æãããšããããæ°Žæ§åªäœäžã§ãªãš
ã³ããšæ¥è§Šããããéåžžãç©ãããªæž©åºŠãçšãã
ããããäžè¬ã«ïŒã50âã®ç¯å²ã§ããããªãšã³ã
ã®æ§è³ªã«ãããæº¶æ¶²ãç·©è¡ããããå®å®å€ãå ã
ãããåã¯ã€ãªã³ã®åŒ·ããç²åºŠçãä»äžãããã
ã«ãã®ä»ã®æ·»å å€ãå ããããšãã§ãããå Žåã«
ãã€ãŠã¯æ·»å å€ãå€ããããšã«ããããªãšã³ãã®
ã³ã³ããªã¡ãŒã·ãšã³ãå€ããŠç°ãæçµçæç©ãåŸ
ãããšãã§ããããªãããç颿޻æ§å€ãšãªãšã³ã
ã®çµåãããé ååãèµ·ãã®ã«ååãªæéæå®æž©
床ã«ä¿æïŒã€ã³ããŠããŒãïŒãããå Žåã«ãã€ãŠ
ã¯ãç³»ã®çµæ¶åãä¿é²ããããã«ã枩床ããµã€ã¯
ã«åãããæº¶æ¶²æ¡ä»¶ãå€ãããããã®ãæãŸã
ãã
ãªãšã³ãã®æ¿åºŠã¯åºç¯å²ã§ããããmlåœããæ°
ÎŒïœãæ°mgã®ç¯å²ãšããããšãã§ããã
ÎŒïœãæ°mgã®ç¯å²ãšããããšãã§ããã
ççŽ ãã®ä»ã®çæ°Žæ§è¡šé¢ã«çµåããåå±€ãäœæ
ããæ¬¡ãã§åå±€ããªãšã³ãæº¶æ¶²ãšæ¥è§Šãããã®ã
æãŸããããšãå€ããååãªæéçµéåŸãæ¯æé¢
ãé€å»ããã
ããæ¬¡ãã§åå±€ããªãšã³ãæº¶æ¶²ãšæ¥è§Šãããã®ã
æãŸããããšãå€ããååãªæéçµéåŸãæ¯æé¢
ãé€å»ããã
å Žåã«ãã€ãŠã¯ããªãšã³ãã飿¥ãªãšã³ãåå
ãšã®é¢ä¿ã§åºçããã®ãæãŸãããé«ãšãã«ã®ãŒ
æŸå°ãçš®ã ã®æ¶æ©å€çã®äœ¿çšã«ããæ¶æ©ãçãã
ããããšãã§ãããããªã¢ããé žã®å Žåããã«ã
ã¢ã«ããããçš®ã ã®äºå®èœæ§è©Šè¬ãã¿ã³ãã³å
ïŒtanningïŒå€çã®æ¶æ©å€ãçšããããšãã§ããã
æ žé žã®å Žåãããœã©ã¬ã³ããžã¢ãŸå詊è¬çã§æ¶æ©
ããããšãã§ããã
ãšã®é¢ä¿ã§åºçããã®ãæãŸãããé«ãšãã«ã®ãŒ
æŸå°ãçš®ã ã®æ¶æ©å€çã®äœ¿çšã«ããæ¶æ©ãçãã
ããããšãã§ãããããªã¢ããé žã®å Žåããã«ã
ã¢ã«ããããçš®ã ã®äºå®èœæ§è©Šè¬ãã¿ã³ãã³å
ïŒtanningïŒå€çã®æ¶æ©å€ãçšããããšãã§ããã
æ žé žã®å Žåãããœã©ã¬ã³ããžã¢ãŸå詊è¬çã§æ¶æ©
ããããšãã§ããã
æ¬çºæã説æããããã«ã以äžã®å®éšãè¡ã€
ããå®éšã®ç®çã¯ãªãããåå±€äžã«æŽç¶ãšé åã
ãæäœã®é»åé¡åŸ®é¡åçãäœæããããšã§ãã€
ããè é£ã®åé¡ã鲿¢ããããã«éã®ã°ãªããã
䜿çšãããã°ãªãããã³ããžãªã³ãççŽ åã³ãªã
ããåå±€ã§è¢«èŠãã宀枩ã§ãã€ã¯ãã¿ã€ã¿ãŒã»ãŠ
ãšã«ïŒåååïŒäžã®æ°æ»Žã®æäœæº¶æ¶²ã«æµ®ãã°ã
ããã°ãªãããåãåºããåŸæ°æ»Žã®æ°Žã§æŽæµãã
ïŒïŒ ã®é ¢é žã©ãŠããŒã«ã§é°æ§ã«æè²ãããç¡«é žã¢
ã³ã¢ããŠã ã§ã®æ²éãQAEâSephadexïŒåååïŒ
ã§ã®ã¯ãããã°ã©ãã€ãŒåã³SephadexG200ïŒå
ååïŒã«ããã²ã«éã«ãããæäœãè ¹æ°Žæ¶²ãã
粟補ããã
ããå®éšã®ç®çã¯ãªãããåå±€äžã«æŽç¶ãšé åã
ãæäœã®é»åé¡åŸ®é¡åçãäœæããããšã§ãã€
ããè é£ã®åé¡ã鲿¢ããããã«éã®ã°ãªããã
䜿çšãããã°ãªãããã³ããžãªã³ãççŽ åã³ãªã
ããåå±€ã§è¢«èŠãã宀枩ã§ãã€ã¯ãã¿ã€ã¿ãŒã»ãŠ
ãšã«ïŒåååïŒäžã®æ°æ»Žã®æäœæº¶æ¶²ã«æµ®ãã°ã
ããã°ãªãããåãåºããåŸæ°æ»Žã®æ°Žã§æŽæµãã
ïŒïŒ ã®é ¢é žã©ãŠããŒã«ã§é°æ§ã«æè²ãããç¡«é žã¢
ã³ã¢ããŠã ã§ã®æ²éãQAEâSephadexïŒåååïŒ
ã§ã®ã¯ãããã°ã©ãã€ãŒåã³SephadexG200ïŒå
ååïŒã«ããã²ã«éã«ãããæäœãè ¹æ°Žæ¶²ãã
粟補ããã
å±€ã¯ä»¥äžã®éã圢æããããããã³ïŒåååïŒ
ãã©ãäžã®ç©ºæ°âæ°Žçé¢äžã«ãªãããã®ãããµã³
æº¶æ¶²ãæ°æ»Žå±éãããããšã«ãããåå±€ã圢æã
ããççŽ ã§æ°ãã被èŠããé»åé¡åŸ®é¡ã®ã°ãªãã
ãçé¢ãéããçåæ°ŽçŽ é£éãçæ°Žæ§ã®ççŽ è¡šé¢
ã«åœæ¥ã極æ§åºã氎溶液ã«é¢ããç¶æ ã§ããªãã
ãåå±€ãæåºãããããã©ãã®è¡šé¢ããªãããã
ãªããªãããã«æåŒããã°ãªããã空æ°äžã«åã
åºããäžæ»Žã®æäœæº¶æ¶²ã«ç§»ããã
ãã©ãäžã®ç©ºæ°âæ°Žçé¢äžã«ãªãããã®ãããµã³
æº¶æ¶²ãæ°æ»Žå±éãããããšã«ãããåå±€ã圢æã
ããççŽ ã§æ°ãã被èŠããé»åé¡åŸ®é¡ã®ã°ãªãã
ãçé¢ãéããçåæ°ŽçŽ é£éãçæ°Žæ§ã®ççŽ è¡šé¢
ã«åœæ¥ã極æ§åºã氎溶液ã«é¢ããç¶æ ã§ããªãã
ãåå±€ãæåºãããããã©ãã®è¡šé¢ããªãããã
ãªããªãããã«æåŒããã°ãªããã空æ°äžã«åã
åºããäžæ»Žã®æäœæº¶æ¶²ã«ç§»ããã
ïŒå®éšã«ãããŠã¯ã150ïœïŒã®å¡©åãããªãŠã ã
50ïœïŒã®TrisïŒPHã8.1ïŒäžã®250ÎŒïœïŒmlã®æäœã«
10æéããããåŸããžãããããšãã«âããªã¹ã
ã¢ããžã«ãšã¿ããŒã«ã¢ãã³åå±€äžã«ç·ç¶ã«é åã
ãã¢ã³ããžãããããšãã«æäœãåŸãã第äºã®å®
éšã§ã¯ãäžèšãªããããšããªã¹ãã¢ããžã«ã³ãªã³
ãšã®ïŒïŒïŒã®ã¢ã«æ¯ã®æ··åç©ãçšããŠããªããã
åå±€ã®çµæãå€ããã
50ïœïŒã®TrisïŒPHã8.1ïŒäžã®250ÎŒïœïŒmlã®æäœã«
10æéããããåŸããžãããããšãã«âããªã¹ã
ã¢ããžã«ãšã¿ããŒã«ã¢ãã³åå±€äžã«ç·ç¶ã«é åã
ãã¢ã³ããžãããããšãã«æäœãåŸãã第äºã®å®
éšã§ã¯ãäžèšãªããããšããªã¹ãã¢ããžã«ã³ãªã³
ãšã®ïŒïŒïŒã®ã¢ã«æ¯ã®æ··åç©ãçšããŠããªããã
åå±€ã®çµæãå€ããã
第äžã®å®éšã§ã¯ãïŒãïŒæéã®ã€ã³ããŠããŒã·
ãšã³ã®åŸé»åé¡åŸ®é¡ã§èгå¯ã§ãããã¿ãŒã³ã¯ç·ç¶
ã§ãã€ããç·ç¶ãã¿ãŒã³ã¯æšªæ¹åééïŒäžå¿éè·
é¢ïŒã150±10â«ã®æè²æé€ã¹ãã©ã€ãïŒstainâ
excluding stripeïŒãç¹åŸŽãšãããåã¹ãã©ã€ã
ã¯ããèªäœçްãæè²ç·ã«ããäžå€®ã§åå²ãããŠã
ããé«åçã§èгå¯ãããšçŽ40â«ã®ééã®æšªç·ãã
ãªãã¡æ¡çŽïŒstriationïŒãããããšãããããã
ã®åãè§£æãããšãäž¡æ¹ã®Fabè ããªãããåå±€
ãšçµåããFcå°Ÿéšã溶液äžã«çªåºããæ æ§ã§ã
IgGååãå å¡«ãããŠããããšã容æã«ãããã
ã¹ãã©ã€ãã¯FabâFcâFabå¹³é¢ãšãäºãå¹³ãã«
ç©ã¿éãªã€ãŠã§ããåååã«çžåœãããæ¡çŽã¯
Fcå°Ÿéšãäžã«ããŠèŠãåã ã®æäœååã«çžåœã
ããã¹ãã©ã€ãåã³æ¡çŽã®ééã¯ïŒžç·çµæ¶åŠãã
æ±ãã察å¿ããååã®å¯žæ³142â«åã³50â«ãšè¯ã
äžèŽããã
ãšã³ã®åŸé»åé¡åŸ®é¡ã§èгå¯ã§ãããã¿ãŒã³ã¯ç·ç¶
ã§ãã€ããç·ç¶ãã¿ãŒã³ã¯æšªæ¹åééïŒäžå¿éè·
é¢ïŒã150±10â«ã®æè²æé€ã¹ãã©ã€ãïŒstainâ
excluding stripeïŒãç¹åŸŽãšãããåã¹ãã©ã€ã
ã¯ããèªäœçްãæè²ç·ã«ããäžå€®ã§åå²ãããŠã
ããé«åçã§èгå¯ãããšçŽ40â«ã®ééã®æšªç·ãã
ãªãã¡æ¡çŽïŒstriationïŒãããããšãããããã
ã®åãè§£æãããšãäž¡æ¹ã®Fabè ããªãããåå±€
ãšçµåããFcå°Ÿéšã溶液äžã«çªåºããæ æ§ã§ã
IgGååãå å¡«ãããŠããããšã容æã«ãããã
ã¹ãã©ã€ãã¯FabâFcâFabå¹³é¢ãšãäºãå¹³ãã«
ç©ã¿éãªã€ãŠã§ããåååã«çžåœãããæ¡çŽã¯
Fcå°Ÿéšãäžã«ããŠèŠãåã ã®æäœååã«çžåœã
ããã¹ãã©ã€ãåã³æ¡çŽã®ééã¯ïŒžç·çµæ¶åŠãã
æ±ãã察å¿ããååã®å¯žæ³142â«åã³50â«ãšè¯ã
äžèŽããã
50ÎŒïœïŒmlã®æäœæ¿åºŠåã³15æéã®ã€ã³ããŠã
ãŒã·ãšã³ä»¥å€äžèšã®å®éšãè¡ã€ãŠãïŒè§åœ¢é åã®
æäœã芳å¯ãããïŒè§åœ¢é åã¯ã150±10â«ã®é
éïŒäžå¿éè·é¢ïŒãæãã倧ããªæè²æé€èŠçŽ ã®
ïŒè§åœ¢ç³»ãç¹åŸŽãšããçµæ¶æ§é ã§ãããé åé å
ã®åºããã¯å€§ããã¯ãªãããé åå ã®é å床ã¯é«
ãã€ãããããé åããã®å åŠçåæã¯ïŒè§åœ¢æ Œ
åã瀺ããã¿ãŒã³ãäžãããåæã¯å°ããšãïŒæ¬¡
ïŒçŽ60â«ã®åè§£èœã«çžåœããïŒã«ãŸã§åãã ã
ãŒã·ãšã³ä»¥å€äžèšã®å®éšãè¡ã€ãŠãïŒè§åœ¢é åã®
æäœã芳å¯ãããïŒè§åœ¢é åã¯ã150±10â«ã®é
éïŒäžå¿éè·é¢ïŒãæãã倧ããªæè²æé€èŠçŽ ã®
ïŒè§åœ¢ç³»ãç¹åŸŽãšããçµæ¶æ§é ã§ãããé åé å
ã®åºããã¯å€§ããã¯ãªãããé åå ã®é å床ã¯é«
ãã€ãããããé åããã®å åŠçåæã¯ïŒè§åœ¢æ Œ
åã瀺ããã¿ãŒã³ãäžãããåæã¯å°ããšãïŒæ¬¡
ïŒçŽ60â«ã®åè§£èœã«çžåœããïŒã«ãŸã§åãã ã
æäœãClqãšé¯äœåœ¢æãããå®éšãããã«è¡ã€
ããé¯åã®ããã«ãDNPâPE被èŠã°ãªãããïŒ
æé50ÎŒïœïŒmlã®æäœã«ããããæ¬¡ãã§ã第äžå®
éšãšåæ§ã«ãããã«10æééå°ã®Clqã«ããã
ããåŸãããé»åé¡åŸ®é¡åçã¯ç·ç¶é ååã³ïŒè§
ç¶ã®é åã®äž¡æ¹ã瀺ãããïŒè§åœ¢é åã®é åã¯ã
倧ããåã³éã«ãããŠæäœåç¬ã®å Žåãšåæ§ã§ã
ã€ãããååŠçãããšãéèŠãªçžéãçŸãããã
Clqãæããæäœæ Œåã§ã¯ãé åã®äžã€ã®å€§ããª
èŠçŽ ããæ¬¡ã®èŠçŽ ãžæè²æé€ãã¯ã€ãã亀äºã«ãª
ã€ãŠããããšãããã€ãã飿¥ããèŠçŽ éã®çžé
ã¯18åã®ïŒã®èŒªããã¬ãã«ïŒcontour lebelïŒã§
ãã€ããæäœåç¬ã®å Žåãšå¯Ÿç §çã«ãçžéã18å
ã®ïŒã®ã¬ãã«ãã倧ãããªãããšã¯ãªãã€ãã
Clqçµåã¯ãFcå°Ÿéšã®æè²ãã¿ãŒã³ãããããã
æŽç¶ãšéåããFabè ã®æè²ãã¿ãŒã³ã«åœ±é¿ãäž
ããã
ããé¯åã®ããã«ãDNPâPE被èŠã°ãªãããïŒ
æé50ÎŒïœïŒmlã®æäœã«ããããæ¬¡ãã§ã第äžå®
éšãšåæ§ã«ãããã«10æééå°ã®Clqã«ããã
ããåŸãããé»åé¡åŸ®é¡åçã¯ç·ç¶é ååã³ïŒè§
ç¶ã®é åã®äž¡æ¹ã瀺ãããïŒè§åœ¢é åã®é åã¯ã
倧ããåã³éã«ãããŠæäœåç¬ã®å Žåãšåæ§ã§ã
ã€ãããååŠçãããšãéèŠãªçžéãçŸãããã
Clqãæããæäœæ Œåã§ã¯ãé åã®äžã€ã®å€§ããª
èŠçŽ ããæ¬¡ã®èŠçŽ ãžæè²æé€ãã¯ã€ãã亀äºã«ãª
ã€ãŠããããšãããã€ãã飿¥ããèŠçŽ éã®çžé
ã¯18åã®ïŒã®èŒªããã¬ãã«ïŒcontour lebelïŒã§
ãã€ããæäœåç¬ã®å Žåãšå¯Ÿç §çã«ãçžéã18å
ã®ïŒã®ã¬ãã«ãã倧ãããªãããšã¯ãªãã€ãã
Clqçµåã¯ãFcå°Ÿéšã®æè²ãã¿ãŒã³ãããããã
æŽç¶ãšéåããFabè ã®æè²ãã¿ãŒã³ã«åœ±é¿ãäž
ããã
äžèšããŒã¿ããæãããªéããæ¬çºæã«ããã
容æã«çµæ¶åããããšãã§ããªãååç©ã®ç·ç¶é
ååã³çµæ¶ã圢æããããšãã§ãããåŸã€ãŠãå
åŠæ§é ã®ç ç©¶ã«çšããããã®ã¿ãªãããåæã°ãª
ããããã€ã«ã¿ãŒãšããŠå åŠç³»ã«çšããããè§Šåª
ãšããŠçšãããã黿°ãã©ã³ã¹ããã·ãšã³ã«çšã
ããããããã¯ãã€ã«ã ãããªããŒçãšããŠçšã
ããããããšãã§ããæ°èŠãªçµæç©ãåŸããã
ã«ãæ¬çºæãå©çšããããšãã§ããã
容æã«çµæ¶åããããšãã§ããªãååç©ã®ç·ç¶é
ååã³çµæ¶ã圢æããããšãã§ãããåŸã€ãŠãå
åŠæ§é ã®ç ç©¶ã«çšããããã®ã¿ãªãããåæã°ãª
ããããã€ã«ã¿ãŒãšããŠå åŠç³»ã«çšããããè§Šåª
ãšããŠçšãããã黿°ãã©ã³ã¹ããã·ãšã³ã«çšã
ããããããã¯ãã€ã«ã ãããªããŒçãšããŠçšã
ããããããšãã§ããæ°èŠãªçµæç©ãåŸããã
ã«ãæ¬çºæãå©çšããããšãã§ããã
ææãããå
å€ïŒfluorescerïŒã®ãããªçºè²
å£ãäŸãã°èæ±èçœè³ªãèç·çŽ ããã¢ã°ããã³ç
ãé åãããŠãåå æ¿ïŒpolarizerïŒããã€ã«ã¿
ãŒãããå å€ãã¢ã³ããçãšããŠäœçšãããããš
ãã§ããã
å£ãäŸãã°èæ±èçœè³ªãèç·çŽ ããã¢ã°ããã³ç
ãé åãããŠãåå æ¿ïŒpolarizerïŒããã€ã«ã¿
ãŒãããå å€ãã¢ã³ããçãšããŠäœçšãããããš
ãã§ããã
æ¬çºæã¯åºç¯å²ã®ææ©ååç©ã®åäžååå±€ãç©
å±€ã®çµæ¶äœã補é ããç°¡åãã€è¿ éãªæ¹æ³ãæäŸ
ããããã®æ¹æ³ã¯ãååç©ã®ç ç©¶ãšãšãã«ãåºç¯
å²ãªçšéãæããæ°èŠãªçæç©ã®è£œé ã«å©çšãã
ãã
å±€ã®çµæ¶äœã補é ããç°¡åãã€è¿ éãªæ¹æ³ãæäŸ
ããããã®æ¹æ³ã¯ãååç©ã®ç ç©¶ãšãšãã«ãåºç¯
å²ãªçšéãæããæ°èŠãªçæç©ã®è£œé ã«å©çšãã
ãã
æ¬çºæã¯ãæç¢ºã«çè§£ããããã«ãäŸã«ãã詳
现ã«èª¬æããããç¹èš±è«æ±ã®ç¯å²å ã«ãããŠçš®ã
ã®å€æŽãããããšãã§ããã®ã¯æããã§ããã
现ã«èª¬æããããç¹èš±è«æ±ã®ç¯å²å ã«ãããŠçš®ã
ã®å€æŽãããããšãã§ããã®ã¯æããã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ååãåååå±€ãšããŠæ¯èŒçäœãèªç±ãšãã«
ã®ãŒã®ç¶æ ã«é åããæ¹æ³ã§ãã€ãŠãåèšåå
ã¯ãå°ããšãéšåçã«æ¥µæ§æº¶åªã«å¯æº¶ã§ãããæŽ
ç¶ãšããé åã圢æããããšãã§ãããã€èŠªæ²¹æ§
é ååã³èŠªæ°Žæ²¹é åãæããç颿޻æ§å€ãšçµåã
ãããšãã§ããååã§ãããåèšç颿޻æ§å€ã¯å
èšååãšåèšèŠªæ°Žæ§é åã«ãããŠçµåããææ®µã
æãã çµåæ¡ä»¶äžã§ãåèšååã®æ¥µæ§æº¶åªæº¶æ¶²ãšãå
èšæº¶æ¶²ã®ã»ãŒè¡šé¢ã«ããåèšç颿޻æ§å€ã®åå±€ãš
ãçµåãããã€ãŠåèšååãšåèšç颿޻æ§å€ãšã
çµåããããã㊠混åç©ãååãªæéæå®æž©åºŠã«ä¿æïŒã€ã³ããŠ
ããŒãïŒããŠåèšååãåååå±€ãšããŠé åãã
ãããšãå«ãæ¹æ³ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®æ¹æ³ã«ãã
ãŠãåèšç颿޻æ§å€ã®åå±€ãåºäœè¡šé¢ã«çµåãã
ãæ¹æ³ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé åã¯ç¬¬ïŒé ã«èšèŒã®æ¹
æ³ã«ãããŠãåèšååãå°ããšãçŽ5000ã®ååé
ãæããé«ååã§ããæ¹æ³ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã«èšèŒã®æ¹æ³ã«ã
ããŠãåèšååãããªã¢ããé žã§ããæ¹æ³ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®æ¹æ³ã«ãã
ãŠãåèšååãããªãã¯ã¬ãªããã§ãããåèšæ
段ããªãªãŽãã¯ã¬ãªããã§ããæ¹æ³ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®æ¹æ³ã«ãã
ãŠãåèšååã®åå±€ãšç¬¬äºã®ååã®æ¥µæ§æº¶åªæº¶æ¶²
ãšãçµåãããåèšç¬¬äºååãæŽç¶ãšãã第äºå
ååå±€ãšããŠåèšååãšçµåããã®ã«ååãªæé
æ··åç©ãæå®æž©åºŠã«ä¿æããæ¹æ³ã ïŒ èŠªæ²¹æ§é ååã³èŠªæ°Žæ§é åãæããç颿޻æ§
å€ãšåèšç颿޻æ§å€ã®åèšèŠªæ°Žæ§é åãšçµåãã
é äœåãšã䜿çšããããšã«ãããåèšé äœåãšç¹
å®ã®çµåå¯Ÿãæ§æããææ©å容äœãåååå±€ãšã
ãŠæ¯èŒçäœãèªç±ãšãã«ã®ãŒç¶æ ã«é åããæ¹æ³
ã§ãã€ãŠã é äœåâå容äœçµåæ¡ä»¶äžã§ãåèšå容äœã®æ¥µ
æ§æº¶åªæº¶æ¶²ãšåèšæº¶æ¶²ã®ã»ãŒè¡šé¢ã«ããåèšçé¢
掻æ§å€ã®åå±€ãšãçµåããã åèšå容äœãåèšé äœåãšçµåãåååå±€ãšã
ãŠæŽç¶ãšããé åããšãã®ã«ååãªæéãæ··åç©
ãæå®æž©åºŠã«ä¿æïŒã€ã³ããŠããŒãïŒãã ããšãå«ãæ¹æ³ã ïŒ ç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èšèŒã®æ¹æ³ã«ãã
ãŠãåèšå容äœãæäœã§ããæ¹æ³ã
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US442066 | 1982-11-16 | ||
| US06/442,066 US4489133A (en) | 1982-11-16 | 1982-11-16 | Two-dimensional crystallization technique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59108000A JPS59108000A (ja) | 1984-06-22 |
| JPH0521880B2 true JPH0521880B2 (ja) | 1993-03-25 |
Family
ID=23755405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58213413A Granted JPS59108000A (ja) | 1982-11-16 | 1983-11-15 | äºæ¬¡å çµæ¶åæ¹æ³ |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4489133A (ja) |
| EP (1) | EP0116751B1 (ja) |
| JP (1) | JPS59108000A (ja) |
| AT (1) | ATE28219T1 (ja) |
| DE (1) | DE3372384D1 (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4600631A (en) * | 1984-05-01 | 1986-07-15 | Massachusetts Institute Of Technology | Ultra tough plastic material |
| FR2564004B1 (fr) * | 1984-05-10 | 1993-04-09 | Commissariat Energie Atomique | Procede de fabrication d'un film mince comportant au moins une couche monomoleculaire de molecules non amphiphiles |
| US5173365A (en) * | 1985-03-25 | 1992-12-22 | Nanofilm Corporation | Ultra-thin molecular film |
| US4634599A (en) * | 1985-05-02 | 1987-01-06 | General Electric Company | Method for making ordered monolayers of macromolecules |
| US4668584A (en) * | 1985-12-23 | 1987-05-26 | General Electric Company | Method for forming 2-D crystals of proteins and macromolecules |
| US4859538A (en) * | 1986-11-20 | 1989-08-22 | Ribi Hans O | Novel lipid-protein compositions and articles and methods for their preparation |
| US5004566A (en) * | 1987-02-06 | 1991-04-02 | Geo-Centers, Inc. | Process for fabrication of lipid microstructures from dry organic solvent |
| US4877501A (en) * | 1987-02-06 | 1989-10-31 | Schnur Joel M | Process for fabrication of lipid microstructures |
| US4743583A (en) * | 1987-07-20 | 1988-05-10 | Temple University | Sustained release protein compositions and method for making |
| US4833233A (en) * | 1987-08-20 | 1989-05-23 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Human serum albumin crystals and method of preparation |
| US5491097A (en) * | 1989-06-15 | 1996-02-13 | Biocircuits Corporation | Analyte detection with multilayered bioelectronic conductivity sensors |
| US5156810A (en) * | 1989-06-15 | 1992-10-20 | Biocircuits Corporation | Biosensors employing electrical, optical and mechanical signals |
| US5268305A (en) * | 1989-06-15 | 1993-12-07 | Biocircuits Corporation | Multi-optical detection system |
| DE3939973A1 (de) * | 1989-12-02 | 1991-06-06 | Basf Ag | Zweidimensional kristallisierte makromolekuelschichten |
| US5415999A (en) * | 1993-07-09 | 1995-05-16 | Biocircuits Corporation | Fluorescent lipid polymer-macromolecular ligand compositions as detection element in ligand assays |
| CA2199149A1 (en) * | 1994-09-13 | 1996-03-21 | Hans O. Ribi | Direct and indirect modulation of spectrophotometric changes in lipid layer in measuring analytes |
| US5985356A (en) * | 1994-10-18 | 1999-11-16 | The Regents Of The University Of California | Combinatorial synthesis of novel materials |
| US6051272A (en) * | 1996-03-15 | 2000-04-18 | The Board Of Trustees Of The University Of Illinois | Method for synthesizing organoapatites on to surgical metal alloys |
| WO2002043856A2 (en) * | 2000-10-24 | 2002-06-06 | Fatemeh Mojtabai | Ordered two-and three-dimensional structures of amphiphilic molecules |
| US20030119060A1 (en) * | 2001-08-10 | 2003-06-26 | Desrosiers Peter J. | Apparatuses and methods for creating and testing pre-formulations and systems for same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1025772A (en) * | 1972-06-26 | 1978-02-07 | Ivar Giaever | Method and apparatus for detection and purification of proteins and antibodies |
-
1982
- 1982-11-16 US US06/442,066 patent/US4489133A/en not_active Expired - Fee Related
-
1983
- 1983-11-09 AT AT83306837T patent/ATE28219T1/de not_active IP Right Cessation
- 1983-11-09 DE DE8383306837T patent/DE3372384D1/de not_active Expired
- 1983-11-09 EP EP19830306837 patent/EP0116751B1/en not_active Expired
- 1983-11-15 JP JP58213413A patent/JPS59108000A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ATE28219T1 (de) | 1987-07-15 |
| EP0116751A3 (en) | 1984-11-07 |
| EP0116751A2 (en) | 1984-08-29 |
| DE3372384D1 (en) | 1987-08-13 |
| JPS59108000A (ja) | 1984-06-22 |
| US4489133A (en) | 1984-12-18 |
| EP0116751B1 (en) | 1987-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0521880B2 (ja) | ||
| Uzgiris et al. | Two-dimensional crystallization technique for imaging macromolecules, with application to antigenâantibodyâcomplement complexes | |
| Van Oss | Hydrophobicity of biosurfacesâorigin, quantitative determination and interaction energies | |
| US5571568A (en) | Multilayered bioelectronic sensors | |
| JP2577017B2 (ja) | è質âã¿ã³ãã¯è³ªçµæç©åã³è£œå䞊ã³ã«ãããã®èª¿è£œæ³ | |
| US5510481A (en) | Self-assembled molecular films incorporating a ligand | |
| Darst et al. | Two-dimensional crystals of Escherichia coli RNA polymerase holoenzyme on positively charged lipid layers | |
| US5310648A (en) | Composition of matter comprising an imprinted matrix exhibiting selective binding interactions through chelated metals | |
| Kubalek et al. | Two-dimensional crystallization of histidine-tagged, HIV-1 reverse transcriptase promoted by a novel nickel-chelating lipid | |
| CA2331688C (en) | Detection of a target in a sample | |
| US5972720A (en) | Stabilization of metal conjugates | |
| SE462454B (sv) | Maetyta foer anvaendning i biosensorer | |
| WO2004013605A2 (en) | Nanoparticles comprising a mixed monolayer for specific ligand binding | |
| US6602692B1 (en) | Method for immobilizing biomolecules and affinity ligands on polymer carriers | |
| US20040038331A1 (en) | Solid phase synthesis of biomolecule conjugates | |
| US4634599A (en) | Method for making ordered monolayers of macromolecules | |
| Terry et al. | Characterisation of membrane mimetics on a dual polarisation interferometer | |
| US5534620A (en) | Method of heterogenous purification using a bidentate conjugate | |
| GB2221466A (en) | Biologically reactive particles with biological, therapeutic and chromatographic applications | |
| Israelachvili et al. | [26] Direct methods for measuring conformational water forces (hydration forces) between membrane and other surfaces | |
| Sasaki | Control of membrane structure and organization through chemical recognition | |
| Thompson et al. | Dynamics of antibodies on planar model membranes | |
| EP1525210B1 (fr) | Procede de fabrication de puces biologiques | |
| EP0628819A2 (de) | Beschichtete TrÀger, Verfahren zu ihrer Herstellung und ihre Verwendung zur Immobilisierung von BiomolekÌlen an OberflÀchen von Festkörpern | |
| JPH03246300A (ja) | äºæ¬¡å ççµæ¶å巚倧ååç®è |